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Background: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been
widely used in industry with important changes in their usage over time. Few epidemiologic studies have
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evaluated the effect of alkylphenolic compounds on human health.
Objectives: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast
and prostate cancer.
Methods: We carried out a population-based case–control study including 1513 incident cases of breast cancer,
1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to
alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered
different scenarios of exposure and different subtypes of alkylphenolic compounds.
Results: History of occupational exposure to alkylphenolic compounds was modestly associated with breast
cancer (OR = 1.23; 95% CI = 1.01–1.48). Within the different scenarios, the occupational use of domestic
tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02–1.60), while occupational
exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to non-
ylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00–1.47), while
exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic
compounds and prostate cancer, except for a positive association among men occupationally exposed to cos-
metic, hair and personal hygiene products.
Conclusions: Our findings suggest a modest association between breast cancer risk and occupational exposure to
alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These find-
ings warrant further corroboration in other studies.
1. Introduction
Alkylphenolic compounds are organic chemicals generally produced
for the manufacture of alkylphenolic ethoxylates (APE), which are
mainly used as non-ionic surfactants, but also in a wide range of ap-
plications. Nonylphenol (NP), octylphenol (OP) and their ethoxylates
(NPE and OPE, respectively) are the most commonly used alkylphenolic
compounds (Lassen et al., 2013). Exposure to these chemicals can occur
occupationally during their production or with exposure to domestic
and industrial detergents, specialty paints, pesticides, cosmetics and
hair dyes, among others (Lassen et al., 2013), but also as a consequence
of non-occupational exposures, such as diet and water intake, use of
personal care and household cleaning products. Due to the toxicity and
bioaccumulation of alkylphenolic compounds in marine organisms
(Hansen et al., 2002), in 2003 the European Union limited the com-
mercialization of products containing NP and NPE in concentrations
over 0.1% (European Union, 2003). Alkylphenols and short-chain al-
kylphenolic ethoxylates are considered endocrine disruptors, mainly
because of their effects mediated by estrogen receptors (Isidori et al.,
2010; Olsen et al., 2005; Sun et al., 2008; White et al., 1994). NP has
shown estrogenic effects in a number of in vitro (yeast, ZR-75 and MCF-
7 human breast cancer cell lines) and in vivo assays (among rats and
mice), although the potency of this activity was moderately lower than
that of estradiol (in vitro assays showed an activity between 3 and 6
orders of lesser magnitude) (Bontje et al., 2004; Rotroff et al., 2014).
Sex hormones play critical roles in the development of breast and
prostate cancers (Acevedo et al., 2005; Gray et al., 2017; Hess-Wilson
and Knudsen, 2006; Risbridger et al., 2010; Villeneuve et al., 2010a)
and therefore we hypothesized that alkylphenolic compounds could
have an influence on the development of these neoplasms. Over the last
decades, there is growing interest in this field and a consequent in-
creased knowledge of the potential impact of these chemicals on the
environment and on human health (Bergman et al., 2013; Casals-Casas
and Desvergne, 2011; Damstra et al., 2002).
Alkylphenolic compounds are ubiquitous, and they have been de-
tected in rivers and bottled water (Amiridou and Voutsa, 2011; Bergé
et al., 2012; Brix et al., 2010; Navarro et al., 2010), as well as in human
fluids or tissues, such as urine (Calafat et al., 2005), blood
(Gyllenhammar et al., 2012), placenta (Huang et al., 2014), breast milk
(Ademollo et al., 2008; Chen et al., 2010; Sise and Uguz, 2017), adipose
tissue (Ferrara et al., 2011; Geens et al., 2012; Lopez-Espinosa et al.,
2009) and hair biospecimens (Nehring et al., 2017). There is con-
siderable uncertainty in the estimated human daily intake figures. The
daily intake has been estimated to be between in the range of
7.5–30 μg/day (0.1–0.4 μg/kg bw/day) from food, and 2.3 × 104 mg/
kg bw/day from water (Guart et al., 2014; Guenther et al., 2002; Lu
et al., 2007). The highest estimated exposure would occur with the
application of specialty paints (2 mg/kg/day), use pesticides (0.35 μg/
kg/day), cosmetics (0.1 μg/kg/day) and exposure via food packaging
materials (0.2 μg/kg/day) and in a textile factory (4.42 mg/kg/day)
(Bontje et al., 2004).
There are few epidemiologic studies assessing the effect of alkyl-
phenolic compounds on human health. Regarding cancer, occupational
exposure to alkylphenolic compounds has been associated with a higher
risk of male and female breast cancer, and lymphoma (Aschengrau
et al., 1998a; Costas et al., 2015; Villeneuve et al., 2010b). Also, higher
NP and OP levels in urine among patients with uterine leiomyoma re-
lative to controls were observed in two case-control studies in China
(Shen et al., 2013; Zhou et al., 2013). A study assessed the association
of circulating serum levels of NP, OP and other xenoestrogens with
mammographic breast density, which is a marker of breast cancer risk,
with negative results for alkylphenolic compounds (Sprague et al.,
2013). However, the conclusions of this study were hampered by the
high probability of external contamination, as well as to the suspected
short half-lives of these compounds, which thus reflect only recent
exposures (Calafat et al., 2013). Current methods to detect alkylphe-
nolic compounds in biospecimens commonly used in epidemiologic
studies, such as blood serum or plasma, are not sensitive enough and
they are susceptible to contamination. Although not exempt of limita-
tions, assessment of occupational exposures may overcome these flaws,
and it can be used to assess lifetime rather than recent exposures of
these compounds, which is relevant when evaluating diseases with long
latency periods, such as cancer (Martín-Bustamante et al., 2017). The
purpose of the present analysis is to explore whether occupational ex-




Cases were recruited within the MCC-Spain study, a Spanish popu-
lation-based multi-case–control study in which population controls
were enrolled as well as five types of common cancers (breast, prostate,
colorectal, stomach and chronic lymphocytic leukaemia). The recruit-
ment started in 2008 and finished in 2013. In this analysis, we included
incident patients diagnosed of breast (C50, D05.1, D05.7) or prostate
cancer (C61, D07.5) admitted to 21 hospitals in 11 Spanish regions
(Asturias, Barcelona, Cantabria, Gipuzkoa, Girona, Granada, Huelva,
León, Madrid, Navarra and Valencia). Controls were frequency-mat-
ched to cases by sex, age, and region of recruitment and were randomly
selected from the rosters of General Practitioners at the Primary Health
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Centers participating in the study, which cover part of the population
living in the corresponding area, and provides a representative sam-
pling frame given the almost universal public coverage of the national
health system in Spain. We excluded those subjects with communica-
tion difficulties (mental or speaking problems) or physical ability im-
pairment. Response rates among the eligible subjects were 71% for
breast cancer cases, 72% for prostate cancer cases and 53% for controls.
Further details can be found elsewhere (Castaño-Vinyals et al., 2015).
We excluded non-Caucasian participants (N = 118), subjects with
missing information on occupation (N = 62), and homemakers
(N = 410). A total of 1513 incident breast cancer cases, 1095 incident
prostate cancer cases and 3055 controls (1575 females and 1480 males)
were included in these analyses.
2.2. Data collection and exposure assessment
Data were collected through direct interviews conducted by trained
personnel. The questionnaire included basic epidemiologic information
such as age, educational level, family history of cancer, body mass
index (BMI) one year before recruitment, tobacco and alcohol con-
sumption one year before recruitment (Castaño-Vinyals et al., 2015;
Spanish questionnaire available at www.mccspain.org). Lifetime occu-
pational history was assessed for all jobs held for 1 year or more. For
each job reported, information was collected on job title, main activity
or task performed, age at start and end, and shift (day, night or ro-
tating), among others. Each occupation was independently coded by
two industrial hygienists following the national codes of occupation
CNO-94, the Spanish adaptation to the International Standard Classi-
fication of Occupations (ISCO-88). When discrepancies occurred be-
tween the hygienists (20% of job titles), agreement was reached by
consensus.
We applied a job-exposure matrix (JEM), originally developed to
apply it to the MCC-Spain study, to assess exposure to alkylphenolic
compounds which takes into account the changes over time of the al-
kylphenolic compounds used in Spain (Martín-Bustamante et al., 2017).
The JEM considers the use of these compounds between 1931 and 2014
in Spain, given that the participants in the MCC-Spain study reported
occupations between this range of years. In summary, three hygienists
coded frequency (minority or majority of workers involved) and in-
tensity of exposure (including dispersive processes, with shaking or
aerosol generation, or otherwise) to alkylphenolic compounds for all
the job titles by period of time. Intensity and frequency of exposure
were combined in a single score as follows: unlikely = 0, occa-
sional + low intensity = 1, occasional + high intensity = 2, fre-
quent + low intensity = 2 and frequent + high intensity = 3. Exposure
assignment was blind to the case-control status and dichotomized into
exposed and unexposed. This JEM grouped the different job titles po-
tentially exposed to alkylphenolic compounds into 6 different scenarios
of exposure: a) manufacture and use of plastic and rubber products, b)
manufacture and use of paints and lubricants, c) use of industrial ten-
sioactives, d) use of domestic tensioactives, e) use of cosmetic and hair
products and personal hygiene products and f) use of pesticides. This
JEM also assessed common types of alkylphenolic compounds: NPE,
OP/NP, APE and others. APE category includes exposure to a mixture of
ethoxylated compounds, and the category ‘others’ includes job titles
which involved a mixture of alkylphenols and alkylphenolic ethox-
ylates. Occupational exposure to solvents and to pesticides was assigned
using a JEM designed for Spanish working conditions (MatEmESp)
(García et al., 2013).
Fig. 1. Forest plot of associations on alkylphenolic compounds by scenario and type of compound.
*Ajusted for age, region, education level, BMI, smoking, alcohol consumption, occupational shift, exposure to pesticides, exposure to solvents, hormonal contra-
ception, postmenopausal hormone therapy, menopausal status and parity.
**Ajusted for age, region, education level, BMI, smoking, alcohol consumption, occupational shift, exposure to pesticides and exposure to solvents.
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2.3. Statistical analyses
The distribution of potential risk factors between cases and controls
was compared using the Pearson's chi-squared test. Duration, age at
first exposure, time since first exposure and time since last exposure to
alkylphenolic compounds were calculated based on the years at start
and stop reported for each job and the date of interview. These vari-
ables were categorized in three groups using tertiles based on the dis-
tribution among exposed controls. Multivariate unconditional logistic
regression models were used to estimate odds ratios (OR) and 95%
confidence intervals (95% CI) for the association between occupational
exposures and cancer. The variables considered for inclusion in the
multivariable models are shown in the Directed Acyclic Graphs
(Supplemental Fig. 1). Basic adjusted models included age at interview
(< 60, 60–69, ≥70), region of recruitment and educational level
(primary or less, secondary, higher). Final models, in addition to the
basic adjustment, included BMI (< 18.5, 18.5–24.9, 25–29.9 or ≥30),
smoking status (never, current, former), alcohol consumption (never,
current, past), occupational shift (day, permanent night, rotating night,
other rotating shifts), ever previous occupational exposure to solvents
and/or to pesticides, and family history of cancer (breast or prostate,
accordingly). For breast cancer, multivariate models were further ad-
justed for hormonal contraceptives use (ever, never), parity (nulli-
parous, 1 child, 2 children, ≥3 children), menopause status (pre-
menopause, postmenopause) and postmenopausal hormone therapy use
(ever, never), given that these variables are clearly related with breast
cancer risk (Risbridger et al., 2010). For all variables, missing data was
≤10% of subjects, except for alcohol consumption which was 15%.
Missing values were introduced in models as independent categories.
To test for linear trend, ordinal variables were treated as continuous
using midpoints in the categories as category values. Multiplicative
interactions were tested by means of likelihood ratio tests comparing
models with and without interactions. Several sensitivity analyses were
performed. Given that exposure to solvents has been previously asso-
ciated to these cancers and solvents and alkylphenolic compounds may
be correlated, we excluded participants who reported occupational
exposure to solvent compounds to ensure that occupational exposure to
these chemicals was not driving associations between exposure to al-
kylphenols and cancer risk. Also, we classified those who reported oc-
casional and low occupational exposure to alkylphenolic compounds as
non-exposed, and thus we considered only frequent and high exposures,
as a measure of high probability of exposure. We performed analyses on
sub-phenotypes of breast and prostate cancer (hormone receptors status
and Gleason score, respectively). Finally, we further explored adjusting
our models for other measures of socioeconomic status (SES) than
educational level, such as self-reported maternal and paternal SES. All
analyses were conducted using Stata version 14.0 and the forest plot
(Fig. 1) was graphed with R 3.4.1.
2.4. Ethics
The MCC-Spain Study followed the national and international di-
rectives on ethics and data protection (declaration of Helsinki and
Spanish law on confidentiality of data, Organic Law on Data Protection
15/1999-LOPD). All eligible subjects signed an informed consent form
for participation. Study protocol was approved by the Ethical and
Research Committees of each participating center.
3. Results
3.1. Demographic features of participants
Baseline characteristics of participants are described in Table 1.
Compared to female controls, female cases were more likely to be
younger, to have a higher BMI, to be non-smokers and never drinkers,
to have been occupationally exposed to solvents, as well as to have a
family history of breast cancer, and have menarche at a younger age.
Male cases were more likely to have a lower educational level, to have
been occupational exposed to pesticides and to report a family history
of prostate cancer, than male controls (Table 1).
Female controls exposed to alkylphenols were more likely to be
older than the unexposed, to live in the Barcelona region, to have a
lower educational level, to have a higher BMI, to be non-smoker and
never drinkers, to have been occupationally exposed to solvents or
pesticides, to be parous, to have never used hormonal contraceptives, to
be younger at first delivery and to be postmenopausal at the moment of
the interview. Compared to the unexposed, exposed male controls were
more likely to be younger, to have a higher educational level, to live in
the Barcelona region, to report occupational exposure to solvents and/
or to pesticides and to have worked in permanent night shifts (Table 2).
3.2. Associations between breast and prostate cancer and alkylphenolic
compounds
Occupational exposure to alkylphenolic compounds was observed
among 412 breast cancer cases (27.2%) and 342 female controls
(21.7%). Patterns of estimates were in general similar between basic
and fully adjusted models; ORs for fully-adjusted models are reported in
the text unless otherwise specified. Subjects occupationally exposed to
alkylphenolic compounds had a modestly higher risk of breast cancer
(OR = 1.23; 95% CI = 1.01–1.48), compared to the unexposed.
Associations were significant among those who ever worked frequently
exposed and with high intensity of exposure (OR = 1.25; 95%
CI = 1.01–1.55). A short duration (< 6 years) was positively associated
with breast cancer (OR tertile 1 vs. never = 1.34; 95% CI = 1.01–1.77),
although no linear trend was observed with duration of exposure (p-
trend = 0.30). Those starting exposure at an older age (≥29) and those
who started < 30 years since the interview showed positive associa-
tions with breast cancer (OR tertile 3 vs. never = 1.35; 95% CI = 1.04–1.84
and OR tertile 3 vs. never = 1.50; 95% CI = 1.14–1.98, respectively).
Estimates were higher among those whose last exposure occurred later
in the calendar (OR1984–2000 vs. never = 1.32; 95% CI = 0.99–1.76; OR
≥2001 = 1.30; 95% CI = 0.98–1.72; Table 3, p-trend = 0.035). Among
those exposed < 30 years ago for the first time, associations were ob-
served regardless of the duration of exposure (OR duration < 6 = 1.53,
95% CI = 1.04–2.27, and OR duration≥6 = 1.43, 95% CI = 1.04–2.27;
data not shown). Similarly, associations were stronger among those
who were exposed for the first time during the last 30 years and their
last use was on 2001 or onwards (OR = 1.56, 95% CI = 1.12–2.17,
compared with never exposed; data not shown).
A total of 331 prostate cancer cases (30.2%) and 377 male controls
(25.5%) were occupationally exposed to alkylphenolic compounds, but
no significant association was observed (OR = 1.15; 95%
CI = 0.96–1.39). Associations were not significant in relation to the
frequency and intensity of the exposure (OR = 1.18; 95%
CI = 0.88–1.59 among those frequently exposed and with high in-
tensity of exposure compared with never exposed). Duration of ex-
posure, age at first exposure, time since first exposure were not clearly
associated with prostate cancer. A shorter time since last occupational
exposure (< 13 years) to alkylphenolic compounds was associated with
prostate cancer (OR tertile 1 vs. never = 1.36; 95% CI = 1.02–1.81), but no
linear trend was observed (p-trend = 0.709, Table 3). Similarly, asso-
ciations were significant for those whom last exposure occurred on
1997 or onwards (OR ≥1997 vs. never = 1.33; 95% CI = 1.01–1.77; p-
trend = 0.396).
3.3. Associations by scenarios and type of compound
Occupational use of domestic tensioactives, the most common sce-
nario of alkylphenolic compounds use among women, was positively
associated with breast cancer (OR = 1.28; 95% CI = 1.02–1.60).
Women exposed to NPE, the most frequently used compound, had 21%
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Table 1
Descriptive characteristics of controls and cases.










Overallc 1575 (51.0) 1513 (49.0) 1480 (57.5) 1095 (42.5)
Age < 0.001 0.003
< 60 844 (53.6) 974 (64.4) 273 (18.4) 187 (17.1)
60–69 375 (23.8) 344 (22.7) 636 (43.0) 544 (49.7)
≥70 356 (22.6) 195 (12.9) 571 (38.6) 364 (33.2)
Region 0.016 0.004
Barcelona 342 (21.7) 272 (18.0) 591 (39.9) 399 (36.4)
Madrid 325 (20.6) 301 (19.9) 332 (22.4) 308 (28.1)
Others 908 (57.7) 940 (62.1) 557 (37.6) 388 (35.4)
Educational level 0.085 < 0.001
Primary 686 (43.6) 672 (44.4) 767 (51.8) 695 (63.5)
Secondary 516 (32.8) 531 (35.1) 401 (27.1) 234 (21.4)
Higher 373 (23.7) 310 (20.5) 312 (21.1) 166 (15.2)
BMId 0.029 0.575
Underweight < 18.5 34 (2.2) 25 (1.7) 6 (0.4) 2 (0.2)
Normal 18.5–24.99 748 (47.5) 669 (44.2) 359 (24.3) 267 (24.4)
Overweight 25–29.99 451 (28.6) 492 (32.5) 759 (51.3) 584 (53.3)
Obesity > 30 230 (14.6) 258 (17.1) 322 (21.8) 224 (20.5)
Diabetes 0.524 < 0.001
No 1447 (91.9) 1398 (92.4) 1158 (78.2) 921 (84.1)
Yes 122 (7.7) 108 (7.1) 320 (21.6) 170 (15.5)
Alcohol consumption 0.011 0.445
Never 371 (23.6) 321 (21.2) 75 (5.1) 50 (4.6)
Ever - current 884 (56.1) 824 (54.5) 1077 (72.8) 793 (72.4)
Ever - past 97 (6.2) 130 (8.6) 102 (6.9) 89 (8.1)
Smoking 0.002 0.166
Never smoker 878 (55.7) 781 (51.6) 390 (26.4) 323 (29.5)
Current smoker 328 (20.8) 298 (19.7) 296 (20.0) 199 (18.2)
Former smoker 367 (23.3) 430 (28.4) 793 (53.6) 571 (52.1)
Occupational exposure to solvents 0.011 0.358
Never 1419 (90.1) 1319 (87.2) 988 (66.8) 712 (65.0)
Ever 156 (9.9) 194 (12.8) 492 (33.2) 383 (35.0)
Occupational exposure to pesticides 0.055 < 0.001
Never 1426 (90.5) 1337 (88.4) 1171 (79.1) 791 (72.2)
Ever 148 (9.4) 174 (11.5) 308 (20.8) 304 (27.8)
Occupational shifts 0.440 0.171
Day shifts 1183 (75.1) 1175 (77.7) 933 (63.0) 704 (64.3)
Ever permanent night shifts 84 (5.3) 96 (6.3) 161 (10.9) 150 (13.7)
Ever rotating night shiftse 115 (7.3) 122 (8.1) 188 (12.7) 171 (15.6)
Other rotating schedulese 128 (8.1) 108 (7.1) 95 (6.4) 69 (6.3)
Cancer family historyf < 0.001 < 0.001
No 1239 (78.7) 988 (65.3) 1257 (84.9) 828 (75.6)
Yes 274 (17.4) 481 (31.8) 112 (7.6) 226 (20.6)
Age at menarche 0.041
≤13 1002 (63.6) 1038 (68.6) Not applicable
> 13 513 (32.6) 453 (29.9)
Hormonal contraceptives 0.176
Never 744 (47.2) 750 (49.6) Not applicable
Ever 829 (52.6) 758 (50.1)
Parity (number of children) 0.113
Nulliparous 274 (17.4) 291 (19.2) Not applicable
1 239 (15.2) 283 (18.7)
2 571 (36.3) 590 (39.0)
≥3 350 (22.2) 313 (20.7)
Age at first deliveryg 0.694
≤26 584 (50.3) 586 (49.4) Not applicable
> 26 573 (49.4) 594 (50.1)
Menopause status 0.519
Postmenopause 1119 (71.0) 1075 (71.1) Not applicable
Premenopause 433 (27.5) 438 (28.9)
Postmenopausal hormone therapyh 0.426
Never 948 (84.7) 942 (87.6) Not applicable
Ever 114 (10.2) 101 (9.4)
No. = number, % = percentage.
a Percentages do not sum to the total due to missing values.
b Chi squared, calculated without missing values.
c Row percentage, the rest of percentages in the table are column percentages.
d Expressed as weight (kg)/height2 (m2).
e Never permanent night shifts.
f Family history of breast/prostate cancer.
g Among parous women.
h Among postmenopausal women.
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Table 2
Descriptive characteristics among controls by occupational exposure to alkylphenolic compounds.










Overallc 1233 (78.3) 342 (21.7) 1103 (74.5) 377 (25.5) 0.008d
Age 0.001 0.031
< 60 692 (56.1) 152 (44.4) 220 (19.9) 53 (14.1)
60–69 277 (22.5) 98 (28.7) 460 (41.7) 176 (46.7)
≥70 264 (21.4) 92 (26.9) 423 (38.3) 148 (39.3)
Region 0.069 0.001
Barcelona 254 (20.6) 88 (25.7) 409 (37.1) 182 (48.3)
Madrid 265 (21.5) 60 (17.5) 263 (23.8) 69 (18.3)
Others 714 (57.9) 194 (56.7) 431 (39.1) 126 (33.4)
Educational level < 0.001 < 0.001
Primary 427 (34.6) 259 (75.7) 515 (46.7) 252 (66.8)
Secondary 449 (36.4) 67 (19.6) 296 (26.8) 105 (27.9)
Higher 357 (29.0) 16 (4.7) 292 (26.5) 20 (5.3)
BMIe < 0.001 0.954
Underweight < 18.5 30 (2.4) 4 (1.2) 5 (0.5) 1 (0.3)
Normal 18.5–24.99 624 (50.6) 124 (36.3) 268 (24.3) 91 (24.1)
Overweight 25–29.99 348 (28.2) 103 (30.1) 566 (51.3) 193 (51.2)
Obesity > 30 155 (12.6) 75 (21.9) 243 (22.0) 79 (21.0)
Diabetes 0.133 0.817
No 1140 (92.5) 307 (89.8) 865 (78.4) 293 (77.7)
Yes 89 (7.2) 33 (9.6) 237 (21.5) 83 (22.0)
Alcohol consumption 0.019 0.145
Never 278 (22.5) 93 (27.2) 60 (5.4) 15 (4.0)
Ever - current 719 (58.3) 165 (48.2) 808 (73.3) 269 (71.4)
Ever - past 72 (5.8) 25 (7.3) 69 (6.3) 33 (8.8)
Smoking 0.002 0.234
Never smoker 664 (53.9) 214 (62.6) 292 (26.5) 98 (26.0)
Current smoker 256 (20.8) 72 (21.1) 231 (20.9) 65 (17.2)
Former smoker 311 (25.2) 56 (16.4) 579 (52.5) 214 (56.8)
Occupational exposure to solvents 0.002 < 0.001
Never 1126 (91.3) 293 (85.7) 858 (77.8) 130 (34.5)
Ever 107 (8.7) 49 (14.3) 245 (22.2) 247 (65.5)
Occupational exposure to pesticides < 0.001 < 0.001
Never 1161 (94.2) 265 (77.5) 897 (81.3) 274 (72.7)
Ever 71 (5.8) 77 (22.5) 206 (18.7) 102 (27.1)
Occupational shifts 0.082 < 0.001
Day shifts 933 (75.7) 250 (73.1) 728 (66.0) 205 (54.4)
Ever permanent night shifts 57 (4.6) 27 (7.9) 95 (8.6) 66 (17.5)
Ever rotating night shiftsf 93 (7.5) 22 (6.4) 127 (11.5) 61 (16.2)
Other rotating schedulesf 104 (8.4) 24 (7.0) 74 (7.2) 21 (5.6)
Cancer family historyg 0.912 0.392
No 973 (78.9) 266 (77.8) 930 (84.3) 327 (86.7)
Yes 216 (17.5) 58 (17.0) 87 (7.9) 25 (6.6)
Age at menarche 0.275
≤13 794 (64.4) 208 (60.8) Not applicable
> 13 394 (32.0) 119 (34.8)
Hormonal contraceptives 0.022
Never 564 (45.7) 180 (52.6) Not applicable
Ever 668 (54.2) 161 (47.1)
Parity (number of children)h < 0.001
Nulliparous 238 (19.3) 36 (10.5) Not applicable
1 189 (15.3) 50 (14.6)
2 447 (36.3) 124 (36.3)
≥3 255 (20.7) 95 (27.8)
Age at first deliveryg < 0.001
≤26 418 (46.9) 166 (61.7) Not applicable
> 26 470 (52.7) 103 (38.3)
Menopause status < 0.001
Postmenopause 849 (68.9) 270 (78.9) Not applicable
Premenopause 370 (30.0) 63 (18.4)
Postmenopausal hormone therapyi 0.204
Never 714 (84.1) 234 (86.7) Not applicable
Ever 92 (10.8) 22 (8.1)
No. = number, % = percentage.
a Percentages do not sum to the total due to missing values.
b Chi squared, calculated without missing values.
c Row percentage, the rest of percentages in the table are column percentages.
d Chi-squared test of difference of exposure by sex.
e Expressed as weight (kg)/height2 (m2).
f Never permanent night shifts.
g Family history of breast/prostate cancer.
h Among parous women.
i Among postmenopausal women.
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increased probability of cancer that the unexposed (OR = 1.21; 95%
CI = 1.00–1.47). Occupational exposure in other scenarios or to other
compounds showed mostly similar non-statistically significant asso-
ciations (Fig. 1).
In general, we did not observe associations between the different
scenarios and specific types of alkylphenolic compounds and prostate
cancer (Fig. 1). An exception was the occupational use of cosmetic, hair
and personal hygiene products, which was associated with nearly three-
fold risk compared to the unexposed (OR = 2.97; 95% CI = 1.15–7.69),
although sample size was small (8 controls and 15 cases).
3.4. Sensitivity analyses
Among those unexposed to solvents, estimates were usually above
the unity, and the ORs for the association between ever exposure to
alkylphenolic compounds and breast cancer (OR = 1.19; 95%
CI = 0.97–1.47) was similar to the overall ORs for whole population
(Table 3) although it was no longer statistically significant (Supple-
mental Table 1). When we considered only those exposures that were
frequent and/or of high intensity, conclusions were mostly similar
(Supplemental Table 2). Adjusting models for maternal or paternal SES
yielded similar conclusions. No significant interactions were detected
between BMI, menopausal status or education and ever exposure to
alkylphenolic compounds (data not shown). Analyses excluding 138 in
situ breast tumors yielded similar results (ORever vs. never = 1.25; 95%
CI = 1.03–1.51). Analyses by tumor receptors revealed significant as-
sociations with ever exposure for triple negative cancers (OR = 1.83;
95% CI = 1.17–2.87), but not for HER-2 positive or hormonal receptors
positive cancers (OR = 0.91; 95% CI = 0.62–1.35; and OR = 1.18; 95%
CI = 0.95–1.47, respectively; Supplemental Table 3). Analyses by
prostate cancer aggressiveness revealed no significant associations
when comparing Gleason scores ≤7 and > 7 versus controls
(OR = 1.17; 95% CI = 0.95–1.45; and OR = 0.75; 95%
CI = 0.50–1.13, respectively; Supplemental Table 4).
4. Discussion
Using data from a large epidemiologic case-control study, we ob-
served a moderate positive association between occupational exposure
to alkylphenolic compounds and breast cancer, and in general, no as-
sociations with prostate cancer. In support of the hypothesis of an as-
sociation between breast cancer and these chemicals, estimates were
stronger among those who ever worked frequently exposed and with
high intensity of exposure, compared with those exposed to alkylphe-
nolic compounds but never with a frequent and high intensity. Within
the different scenarios of exposure, the occupational use of domestic
tensioactives was positively associated with breast cancer, while other
scenarios showed similar, but not statistically significant associations.
The type of compound most frequently used among exposed women
was nonylphenol ethoxylates, which were positively associated with
breast cancer. Overall, no associations were observed for prostate
cancer and occupational use of alkylphenolic compounds. However,
exposures occurred on 1997 or onwards revealed significant associa-
tions, as well as occupational use of cosmetic, hair and personal hygiene
products, although based on a small sample size.
Despite the growing interest in the potential impact of these che-
micals on the environment and on health, data among humans are still
scarce, especially for specific EDC (Bergman et al., 2013; Casals-Casas
and Desvergne, 2011; Damstra et al., 2002). Alkylphenolic compounds
are considered EDC because of their estrogenic and weak anti-andro-
genic activities (Bontje et al., 2004). Recent in vitro and in vivo data
suggested that low-dose alkylphenol exposure promotes mammary al-
terations, and stated that exposure to alkylphenols could be considered
as a tumor promoting environment, while the effect as tumor initiators
was not evident (Chamard-Jovenin et al., 2017). Although with certain
inconsistencies, risks were increased with recent exposures, which
could suggest that the hormone-dependent responses of alkylphenolic
compounds might produce the potential effects in a relatively short
period of time. However, we observed increased risks among women
with triple negative cancer rather than with hormonal receptors posi-
tive cancer, which is not in line with our a priori hypothesis of alkyl-
phenols promoting mammary cell proliferation by binding to estrogen
receptors. Our findings are in accordance with the scarce published
literature on the subject (Aschengrau et al., 1998b; Gray et al., 2017;
Villeneuve et al., 2010a). Occupational exposure to 4-octylphenol and a
higher risk of breast cancer in females has been previously reported in
one study performed in Massachusetts using data from the NIOSH Na-
tional Occupational Exposure Survey. However, these findings need to
be interpreted cautiously as the exposed number of subjects was very
small (6 cases and 5 controls) (Aschengrau et al., 1998b). A European
case-control study reported an increased risk between occupational
exposure to alkylphenolic compounds and breast cancer among males,
although with certain inconsistencies, suggesting that alkylphenolic
compounds could also play a role in the development of this cancer in
men (Villeneuve et al., 2010a).
In accordance with previous literature, breast cancer was associated
in our sample with BMI, tobacco, alcohol consumption, age at me-
narche, and family history of breast cancer (Sun et al., 2017; Winters
et al., 2017). Other exposures related to estrogens trough lifetime
(parity, age at menopause, use of hormonal contraceptives or post-
menopausal hormonal therapy) are also relevant predictors of breast
cancer (Sun et al., 2017; Winters et al., 2017). Although these variables
were not statistically significantly associated with breast cancer in our
bivariate analyses, they were introduced in the fully adjusted model,
similarly to educational level, in order to potentially control for con-
founding and selection bias for these factors. Given that participation
rates were lower in controls than cases, selection bias could have oc-
curred as controls have a higher SES than cases. We therefore controlled
all analyses for educational level, and explored other different measures
of SES, obtaining similar results, which suggests that our results are not
strongly influenced by this potential bias. Sensitivity analyses re-
stricting analyses to the unexposed to solvents, as well as reclassifying
those with occasional and low intensity as unexposed, yielded similar
conclusions. Similarly, associations were not restricted to a particular
scenario, such as the occupational use of pesticides. This suggests that
our results are not driven by confounding for pesticides or organic
solvents, which were previously associated with breast cancer, although
with inconsistences (Engel, 2005; Peplonska et al., 2010). None of the
previous studies examining associations between alkylphenolic com-
pounds and cancer took into account relevant exposure changes over
time. Given the short half-live of these chemicals (Müller et al., 1998)
and the long latency of diseases such as cancer, it is important to use a
method that allows estimating lifetime exposure and that considers the
relevant changes in their use over the years. The use of these com-
pounds has experienced relevant changes throughout last decades
worldwide. For instance, in the United Kingdom, the first use of these
compounds was detected in 1944, while in Spain they were introduced
in 1959 with the opening to international markets. In the 70s, the first
concerns about the toxicity of these compounds and their potential to
bioaccumulate in marine organisms and in the environment appeared,
and voluntary agreements were undertaken to reduce or eliminate the
use and manufacture of these compounds. In 2002–2003 the European
Union established regulations to limit the use of NP and NPE (Bontje
et al., 2004; European Union, 2003; Martín-Bustamante et al., 2017).
This is relevant because 92% of the exposed women and 88% of ex-
posed males in our study had an exposure between 1965 and 2002, i.e.
before regulations took place to reduce these exposures. We found
significant positive associations between breast cancer and both NPE
exposure and use of domestic tensioactives. This is probably due to the
correlation between these two variables, as NPE is the most frequent
compound within the domestic tensioactives scenario (Martín-
Bustamante et al., 2017).
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In general, we found no associations between prostate cancer and
exposure to alkylphenolic compounds. Previous studies suggested a
possible relationship between exposure to endocrine disrupting com-
pounds with estrogenic activity, other than alkylphenols, and an in-
creased prostate cancer risk (Hess-Wilson and Knudsen, 2006). How-
ever, no epidemiologic study has ever evaluated the relationship
between alkylphenolic compounds and prostate cancer. Besides their
estrogenic activity, alkylphenolic compounds may also have weak anti-
androgenic effects, as they can act as partial agonists of androgenic
receptors thus inhibiting the effect of full agonists (Weiss et al., 2009).
Androgens are necessary for cancer prostate development, and an-
drogen receptor signaling has been well characterized in the develop-
ment of prostate cancer metastasis (Zhou et al., 2014). Although they
have been less studied in cancer prostate risk compared with breast
cancer, there is evidence that high doses of estrogens also have direct
effects on the development of the prostate gland and also indirect ef-
fects through the suppression of the hypothalamic pituitary gonadal
axis (Jarred et al., 2000). Metabolism of these sex hormones is complex
and correlated and conversion of androgens to estrogens is mediated by
an enzyme encoded by CYP19A1 (Risbridger et al., 2010; Rothenberger
et al., 2018). Given the complexity of the hormonal metabolism, and
the estrogenic and anti-androgenic effects of alkylphenolic compounds,
further research is needed to disentangle whether and how these
compounds could influence prostate cancer risk.
JEMs for occupational exposure assessment are useful and cost-ef-
ficient tool in large scale studies (Kauppinen, 1996; Kim et al., 2011; Le
Moual et al., 2000; Martín-Bustamante et al., 2017), but they can lead
to substantial misclassification of exposures (Rothman et al., 2007). In
the present analysis, this misclassification would be non-differential as
the exposure assessment was blind to the case-control status. In case of
truly positive associations, it would result in the attenuation of the
estimates for binary and continuous exposures (Pearce et al., 2007;
Steenland et al., 2000). The JEM used in the present analyses was de-
veloped undertaking several strategies to minimize potential sources of
misclassification. Among others, it considered relevant changes over
time in use and manufacture of alkylphenolic compounds in the same
population that it is applied, which probably results in better estimates
of the exposure. However, we could not validate the JEM using biologic
measurements given the short life of these compounds, and the changes
in use over time. Evaluating levels among workers may help better
understanding current exposures, but the scores in our JEM reflect
lifetime exposures which have greatly varied over time. We had the
opportunity to adjust for many potential confounders, including well-
established and other potential risk factors for breast and prostate
cancer. We did not observe clear evidence of confounding by any of
them, although residual confounding cannot be completely discarded in
explaining some of our results. Non-occupational sources of exposure,
such as diet, use of personal care and household cleaning products,
could be relevant sources of alkylphenolic compounds. The JEM ex-
posure scores reflect the probability that occupational exposure con-
tributes significantly to an individual's body burden in comparison to
other sources of exposure. Although we do not expect big differences in
background levels, we were not able to assess non-occupational sources
of these compounds and therefore certain misclassification of the ex-
posure cannot be ruled out. The relatively large sample size of the
study, allowed us to perform several subgroup analysis. Nevertheless,
some of the analyses by scenarios and compound subtypes were based
on small sample sizes. Some of the job titles involving alkylphenols
actually involved a mixture of alkylphenols and alkylphenolic ethox-
ylates, and therefore the JEM that we used did not assign a more spe-
cific category of compound. Some of the reported associations could be
spurious as multiple comparisons were performed in our analysis.
5. Conclusion
To our knowledge, this is the largest study examining the
relationship between occupational exposure to alkylphenolic com-
pounds and breast and prostate cancer. We examined these associations
using a method that considered relevant changes over time in the use of
these compounds, and we adjusted for multiple potential confounding
variables. Our findings suggest a modest association between breast
cancer risk and occupational exposure to alkylphenolic compounds,
while no association with prostate cancer. The elucidation of the role of
alkylphenolic compounds on breast and prostate cancers should shed a
light on the etiology of those tumors and help informing future public
health decisions.
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